Abstract
Dr. Bruce Dull has discussed in-depth the benefit risk assessment in the development of and usage of immunizing agents. It is my task to cover the wide range of other ethical considerations which face investigators and makers of public policy concerned with immunization. Many of the issues have been explored in-depth at a National Conference on Immunization sponsored by HEW in November 1976, and by a series of National Immunization Work Groups convened by the Assistant Secretary for Health of Health, Education and Welfare thereafter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appendix B-2 Report and Recommendations of the National Immunization Work Groups submitted to the Office of the Assistant Secretary for Health. JRB Associates, Inc. March 15, 1977.
National Immunization Conference, Policy Perspective, HEW., P.H. S. November 1976. DHEW Publication # (OS) 77-50039 p.8
Report and Recommendations: Research Involving Children. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, DHEW Publication No. (OS) 77–0004.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Press, New York
About this chapter
Cite this chapter
Cooke, R.E. (1979). Ethical Considerations in the Selection of Cells and the use of Biologicals. In: Petricciani, J.C., Hopps, H.E., Chapple, P.J. (eds) Cell Substrates. Advances in Experimental Medicine and Biology, vol 118. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0997-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0997-0_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0999-4
Online ISBN: 978-1-4684-0997-0
eBook Packages: Springer Book Archive